- Home
- TIRX vs APM Comparison
TIRX vs APM Comparison
Compare TIRX & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIRX
- APM
- Stock Information
- Founded
- TIRX 2010
- APM 2010
- Country
- TIRX China
- APM United Kingdom
- Employees
- TIRX N/A
- APM N/A
- Industry
- TIRX Specialty Insurers
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- TIRX Finance
- APM Health Care
- Exchange
- TIRX Nasdaq
- APM Nasdaq
- Market Cap
- TIRX 4.6M
- APM 4.1M
- IPO Year
- TIRX 2021
- APM 2018
- Fundamental
- Price
- TIRX $1.67
- APM $1.15
- Analyst Decision
- TIRX
- APM
- Analyst Count
- TIRX 0
- APM 0
- Target Price
- TIRX N/A
- APM N/A
- AVG Volume (30 Days)
- TIRX 493.9K
- APM 7.0M
- Earning Date
- TIRX 08-16-2024
- APM 12-20-2024
- Dividend Yield
- TIRX N/A
- APM N/A
- EPS Growth
- TIRX N/A
- APM N/A
- EPS
- TIRX N/A
- APM 0.00
- Revenue
- TIRX $697,733.00
- APM N/A
- Revenue This Year
- TIRX N/A
- APM $157,729.10
- Revenue Next Year
- TIRX N/A
- APM N/A
- P/E Ratio
- TIRX N/A
- APM $345.64
- Revenue Growth
- TIRX N/A
- APM N/A
- 52 Week Low
- TIRX $1.38
- APM $0.46
- 52 Week High
- TIRX $7.40
- APM $17.49
- Technical
- Relative Strength Index (RSI)
- TIRX 48.61
- APM 47.12
- Support Level
- TIRX $1.40
- APM $1.21
- Resistance Level
- TIRX $1.73
- APM $1.30
- Average True Range (ATR)
- TIRX 0.16
- APM 0.75
- MACD
- TIRX -0.01
- APM -0.06
- Stochastic Oscillator
- TIRX 55.10
- APM 4.58
About TIRX TIAN RUIXIANG Holdings Ltd
Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.